Omnicare draws buyout interest from Express Scripts, CVS; Akorn asks Oklahoma not to use its drugs to execute;

@FiercePharma: From the pharma C-suite: Notable, quotable remarks on Asia, emerging markets for Q1. Story | Follow @FiercePharma

@EricPFierce: Drug shortages become way for #Mylan to parry against #Teva but will the FTC care? More | Follow @EricPFierce

@CarlyHFierce: #ICYMI yesterday: Teva CEO 'takes the high road' to rebut Mylan chairman's attack. News | Follow @CarlyHFierce

> Akorn ($AKRX) has asked Oklahoma authorities not to use its products for executions. Story

> Omnicare ($OCR), a supplier of drugs to nursing homes, is drawing interest from potential buyers, including Express Scripts Holding ($ESRX) and CVS Health ($CVS). Story

> GlaxoSmithKline ($GSK) CEO Andrew Witty met with U.K. health officials to voice his concerns before the country finalized changes to its drug pricing system. Report

Medical Device News

@FierceMedDev: Medtronic to test renal denervation as treatment for atrial fibrillation. Article | Follow @FierceMedDev

@VarunSaxena2: ICYMI: Kaiser backs startup in $12.5M round to speed healthcare data integration. News | Follow @VarunSaxena2

@EmilyWFierce: Abbott grabs #FDA OK for early pregnancy blood test. FierceDiagnostics Story | Follow @EmilyWFierce

> Greatbatch spins off neurostimulation unit to speed up growth. Article.

> Ninox gets $10M Series B to get wearable sleep apnea device through regulators. More

Biotech News

@FierceBiotech: Gilead's 'open to suggestion' on its next big M&A splash. Articles | Follow @FierceBiotech

@JohnCFierce: T-Vec panel demonstrates just how accepting the FDA and its panels are when it comes to "meh" cancer drugs. | Follow @JohnCFierce

@DamianFierce: Shouts to the 19 $OPHT workers who won $58M on the New York lottery. Article | Follow @DamianFierce

> Biotech's boom spells a spike in R&D down payments. Article

> Collegium swings for a $75M IPO for its abuse-proof painkiller. More

And Finally... Subbing one serving per day of water or unsweetened tea or coffee for one serving of a sugar-sweetened soft drink or dairy beverage can significantly cut down the incidence of Type 2 diabetes, new research shows. More (sub. req.)

Suggested Articles

After a slow start, Teva's Ajovy launch is improving following the FDA approval for an autoinjector.

After Trump's "Buy American" executive order for essential medicines, the pharma industry is pushing back.

The U.S. is slamming the brakes on its $765 million loan to Kodak amid insider trading allegations and questions about its fitness for the job.